Home > Journals > Minerva Anestesiologica > Past Issues > Minerva Anestesiologica 1998 May;64(5) > Minerva Anestesiologica 1998 May;64(5):257-9

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA ANESTESIOLOGICA

A Journal on Anesthesiology, Resuscitation, Analgesia and Intensive Care


Official Journal of the Italian Society of Anesthesiology, Analgesia, Resuscitation and Intensive Care
Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 2,036


eTOC

 

Vth SECTION
SAH-PATIENTS OUTCOME, COMPLICATIONS AND PREVENTION, FUTURE PROSPECTS  PROCEEDINGS OF THE VIDEOCONFERENCE - October 5, 1996
SUBARACHNOID HEMORRHAGE: A MULTIDISCIPLINARY APPROACH - II


Minerva Anestesiologica 1998 May;64(5):257-9

language: Italian

Future prospects of pharmachological SAH treatment

Carteri A., Billeci D., Copetti E.

Ospedale Regionale «Ca’ Foncello» - Treviso, Divisione Clinicizzata di Neurochirurgia


FULL TEXT  


The aim of pharmacological therapy in sub-arachnoid haemorrhage (SAH) is to prevent cerebral ischemia and consequent events. Vasospasm, energy decrease, alterated Ca++ homeostasis, lactic acidosis and free radicals are responsibles for cerebral ischemic damage. Drug therapy in SAH is necessary before, during and after surgical treatment. Nimodipine is the only drug used today and supported by many clinical trials; scientific trials, on using known and new substances in SAH drug therapy, are in progress.

top of page

Publication History

Cite this article as

Corresponding author e-mail